Antiviral drug discovery for emerging diseases and bioterrorism threats:
Saved in:
| Format: | Electronic eBook |
|---|---|
| Language: | English |
| Published: |
Hoboken, N.J.
Wiley-Interscience
©2005
|
| Subjects: | |
| Online Access: | FRO01 UBG01 Volltext |
| Item Description: | Includes bibliographical references and index Antiviral Drug Discovery gives readers a cutting-edge view of how chemical concepts are being mobilized to develop novel approaches that will effectively confront emerging diseases and biowarfare. Among the many topics discussed are smallpox, the Ebola virus, influenza, SARS, arenaviruses and flaviviruses. Each chapter discusses hypothetical strategies for the discovery of relevant antiviral agents, recent findings related to biochemistry or drug discovery, and advances in the further development of established leads in the area. Timely and informative, this book clearly delineates the efforts |
| Physical Description: | 1 Online-Ressource (x, 420 pages) |
| ISBN: | 0471716707 9780471716709 0471716715 9780471716716 0471668273 9780471668275 |
Staff View
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043385194 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 160222s2005 |||| o||u| ||||||eng d | ||
| 020 | |a 0471716707 |c electronic bk. |9 0-471-71670-7 | ||
| 020 | |a 9780471716709 |c electronic bk. |9 978-0-471-71670-9 | ||
| 020 | |a 0471716715 |c electronic bk. |9 0-471-71671-5 | ||
| 020 | |a 9780471716716 |c electronic bk. |9 978-0-471-71671-6 | ||
| 020 | |a 0471668273 |9 0-471-66827-3 | ||
| 020 | |a 9780471668275 |9 978-0-471-66827-5 | ||
| 024 | 7 | |a 10.1002/0471716715 |2 doi | |
| 035 | |a (ZDB-35-WIC)ocm61514478 | ||
| 035 | |a (OCoLC)61514478 | ||
| 035 | |a (DE-599)BVBBV043385194 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-861 | ||
| 082 | 0 | |a 616.9/1061 |2 22 | |
| 245 | 1 | 0 | |a Antiviral drug discovery for emerging diseases and bioterrorism threats |c edited by Paul F. Torrence |
| 264 | 1 | |a Hoboken, N.J. |b Wiley-Interscience |c ©2005 | |
| 300 | |a 1 Online-Ressource (x, 420 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Antiviral Drug Discovery gives readers a cutting-edge view of how chemical concepts are being mobilized to develop novel approaches that will effectively confront emerging diseases and biowarfare. Among the many topics discussed are smallpox, the Ebola virus, influenza, SARS, arenaviruses and flaviviruses. Each chapter discusses hypothetical strategies for the discovery of relevant antiviral agents, recent findings related to biochemistry or drug discovery, and advances in the further development of established leads in the area. Timely and informative, this book clearly delineates the efforts | ||
| 650 | 4 | |a Pharmaceutical Sciences | |
| 650 | 4 | |a Antiviral Agents / therapeutic use | |
| 650 | 4 | |a Bioterrorism / prevention & control | |
| 650 | 4 | |a Communicable Diseases, Emerging / drug therapy | |
| 650 | 4 | |a Communicable Diseases, Emerging / prevention & control | |
| 650 | 4 | |a Drug Design | |
| 650 | 7 | |a MEDICAL / Infectious Diseases |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Contagious |2 bisacsh | |
| 650 | 7 | |a Antiviral agents |2 fast | |
| 650 | 7 | |a Bioterrorism |2 fast | |
| 650 | 7 | |a Drug development |2 fast | |
| 650 | 4 | |a Antiviral agents | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Antiviral agents | |
| 650 | 4 | |a Drug development | |
| 650 | 4 | |a Bioterrorism | |
| 700 | 1 | |a Torrence, Paul F. |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/book/10.1002/0471716715 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-35-WIC | ||
| 940 | 1 | |q UBG_PDA_WIC | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028803778 | ||
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/0471716715 |l FRO01 |p ZDB-35-WIC |q FRO_PDA_WIC |x Verlag |3 Volltext | |
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/0471716715 |l UBG01 |p ZDB-35-WIC |q UBG_PDA_WIC |x Verlag |3 Volltext | |
Record in the Search Index
| _version_ | 1804175953231872000 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043385194 |
| collection | ZDB-35-WIC |
| ctrlnum | (ZDB-35-WIC)ocm61514478 (OCoLC)61514478 (DE-599)BVBBV043385194 |
| dewey-full | 616.9/1061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.9/1061 |
| dewey-search | 616.9/1061 |
| dewey-sort | 3616.9 41061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02993nmm a2200625zc 4500</leader><controlfield tag="001">BV043385194</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160222s2005 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0471716707</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-471-71670-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780471716709</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-471-71670-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0471716715</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-471-71671-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780471716716</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-471-71671-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0471668273</subfield><subfield code="9">0-471-66827-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780471668275</subfield><subfield code="9">978-0-471-66827-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/0471716715</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-35-WIC)ocm61514478</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)61514478</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043385194</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-861</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9/1061</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antiviral drug discovery for emerging diseases and bioterrorism threats</subfield><subfield code="c">edited by Paul F. Torrence</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, N.J.</subfield><subfield code="b">Wiley-Interscience</subfield><subfield code="c">©2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (x, 420 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Antiviral Drug Discovery gives readers a cutting-edge view of how chemical concepts are being mobilized to develop novel approaches that will effectively confront emerging diseases and biowarfare. Among the many topics discussed are smallpox, the Ebola virus, influenza, SARS, arenaviruses and flaviviruses. Each chapter discusses hypothetical strategies for the discovery of relevant antiviral agents, recent findings related to biochemistry or drug discovery, and advances in the further development of established leads in the area. Timely and informative, this book clearly delineates the efforts</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical Sciences</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiviral Agents / therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bioterrorism / prevention & control</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Communicable Diseases, Emerging / drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Communicable Diseases, Emerging / prevention & control</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Infectious Diseases</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Contagious</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antiviral agents</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bioterrorism</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug development</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiviral agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiviral agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bioterrorism</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Torrence, Paul F.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/0471716715</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-35-WIC</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">UBG_PDA_WIC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028803778</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/0471716715</subfield><subfield code="l">FRO01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">FRO_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/0471716715</subfield><subfield code="l">UBG01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">UBG_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043385194 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:24:28Z |
| institution | BVB |
| isbn | 0471716707 9780471716709 0471716715 9780471716716 0471668273 9780471668275 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028803778 |
| oclc_num | 61514478 |
| open_access_boolean | |
| owner | DE-861 |
| owner_facet | DE-861 |
| physical | 1 Online-Ressource (x, 420 pages) |
| psigel | ZDB-35-WIC UBG_PDA_WIC ZDB-35-WIC FRO_PDA_WIC ZDB-35-WIC UBG_PDA_WIC |
| publishDate | 2005 |
| publishDateSearch | 2005 |
| publishDateSort | 2005 |
| publisher | Wiley-Interscience |
| record_format | marc |
| spelling | Antiviral drug discovery for emerging diseases and bioterrorism threats edited by Paul F. Torrence Hoboken, N.J. Wiley-Interscience ©2005 1 Online-Ressource (x, 420 pages) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index Antiviral Drug Discovery gives readers a cutting-edge view of how chemical concepts are being mobilized to develop novel approaches that will effectively confront emerging diseases and biowarfare. Among the many topics discussed are smallpox, the Ebola virus, influenza, SARS, arenaviruses and flaviviruses. Each chapter discusses hypothetical strategies for the discovery of relevant antiviral agents, recent findings related to biochemistry or drug discovery, and advances in the further development of established leads in the area. Timely and informative, this book clearly delineates the efforts Pharmaceutical Sciences Antiviral Agents / therapeutic use Bioterrorism / prevention & control Communicable Diseases, Emerging / drug therapy Communicable Diseases, Emerging / prevention & control Drug Design MEDICAL / Infectious Diseases bisacsh HEALTH & FITNESS / Diseases / Contagious bisacsh Antiviral agents fast Bioterrorism fast Drug development fast Antiviral agents Medizin Drug development Bioterrorism Torrence, Paul F. Sonstige oth https://onlinelibrary.wiley.com/doi/book/10.1002/0471716715 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Antiviral drug discovery for emerging diseases and bioterrorism threats Pharmaceutical Sciences Antiviral Agents / therapeutic use Bioterrorism / prevention & control Communicable Diseases, Emerging / drug therapy Communicable Diseases, Emerging / prevention & control Drug Design MEDICAL / Infectious Diseases bisacsh HEALTH & FITNESS / Diseases / Contagious bisacsh Antiviral agents fast Bioterrorism fast Drug development fast Antiviral agents Medizin Drug development Bioterrorism |
| title | Antiviral drug discovery for emerging diseases and bioterrorism threats |
| title_auth | Antiviral drug discovery for emerging diseases and bioterrorism threats |
| title_exact_search | Antiviral drug discovery for emerging diseases and bioterrorism threats |
| title_full | Antiviral drug discovery for emerging diseases and bioterrorism threats edited by Paul F. Torrence |
| title_fullStr | Antiviral drug discovery for emerging diseases and bioterrorism threats edited by Paul F. Torrence |
| title_full_unstemmed | Antiviral drug discovery for emerging diseases and bioterrorism threats edited by Paul F. Torrence |
| title_short | Antiviral drug discovery for emerging diseases and bioterrorism threats |
| title_sort | antiviral drug discovery for emerging diseases and bioterrorism threats |
| topic | Pharmaceutical Sciences Antiviral Agents / therapeutic use Bioterrorism / prevention & control Communicable Diseases, Emerging / drug therapy Communicable Diseases, Emerging / prevention & control Drug Design MEDICAL / Infectious Diseases bisacsh HEALTH & FITNESS / Diseases / Contagious bisacsh Antiviral agents fast Bioterrorism fast Drug development fast Antiviral agents Medizin Drug development Bioterrorism |
| topic_facet | Pharmaceutical Sciences Antiviral Agents / therapeutic use Bioterrorism / prevention & control Communicable Diseases, Emerging / drug therapy Communicable Diseases, Emerging / prevention & control Drug Design MEDICAL / Infectious Diseases HEALTH & FITNESS / Diseases / Contagious Antiviral agents Bioterrorism Drug development Medizin |
| url | https://onlinelibrary.wiley.com/doi/book/10.1002/0471716715 |
| work_keys_str_mv | AT torrencepaulf antiviraldrugdiscoveryforemergingdiseasesandbioterrorismthreats |